Based on additional studies in mice, demonstrating that ILC2-derived IL-9 triggers CF-associated inflammation via a complex vicious cycle that includes activation of mast cells, it was speculated that a similar mechanism could support the infection-dependent disease exacerbation in CF. Here, IL9 is linked to infection.